Financial Statements · Financial Reporting

Narafarm OÜ

Official identifier 12139312Record date 31 Dec 2024
Estonia

Report

Legal form
OÜ
Report status
Registered

Dates

Reporting year
2024
Period start
1 Jan 2024
Submitted date
2 Jul 2025

Report

Consolidated
No
Audited
No

Financial metrics

StatementMetricValue
Bilanss, detailneAssets754,153
Bilanss, detailneCash and cash equivalents28,316
Bilanss, detailneCurrent assets78,454
Bilanss, detailneCurrent liabilities86,883
Bilanss, detailneEquity404,148
Bilanss, detailneShare capital at nominal value2,500
Bilanss, detailneNon-current assets675,699
Bilanss, detailneNon-current liabilities263,122
Bilanss, detailneRetained earnings (loss) from previous periods605,496
Income statement scheme 1Depreciation and impairment of non-current assets-105,259
Income statement scheme 1Labour costs-24,933
Income statement scheme 1Revenue271,912
Income statement scheme 1Annual period profit / loss-204,098
Income statement scheme 1Operating profit (loss)-177,114
Income statement scheme 1Profit (loss) before income tax-204,098
Profit distribution proposalRetained earnings (loss) from previous periods605,496
Note: Labour costsEmployees2
Note: Labour costsLabour costs24,933

Linked company

Company: Narafarm OÜ

Source

Estonian e-Business Register Annual Reports open data

View published source

Back to Financial Statements